Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder

NCT01379625 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency
Carnitine Palmitoyltransferase 2 (CPT2) Deficiency
Mitochondrial Trifunctional Protein (TFP) Deficiency
Long-chain 3 hydroxyacylCoA Dehydrogenase (LCHAD) Deficiency

Interventions

DRUG: Triheptanoin

Sponsor

Oregon Health and Science University

Collaborators

[object Object]